These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 126007)

  • 1. The effect of products of fibrinogen digestion by plasmin (P-FDP) on the central nervous system.
    Wiśniewski K; Buczko W; Moniuszko-Jakoniuk J
    Acta Neurobiol Exp (Wars); 1975; 35(3):275-83. PubMed ID: 126007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of fibrinogen degradation products (FDP) on the central nervous system and on the effects of centrally acting drugs.
    Buczko W; Moniuszko-Jakoniuk J
    Pharmacology; 1975; 13(3):252-9. PubMed ID: 1153509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological properties of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations.
    Buczko W; de Gaetano G; Franco R; Donati MB
    Thromb Haemost; 1976 Jun; 35(3):651-7. PubMed ID: 136056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of peptides in the central nervous system function.
    Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):647-54. PubMed ID: 189293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the role of fibrinolysis and fibrinogen degradation products (FDP) in analgesic action of morphine.
    Buczko W; Wiśniewski K
    Thromb Diath Haemorrh; 1972 Dec; 28(3):359-66. PubMed ID: 4265317
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of effects of fibrinogen degradation products on specific binding of [3H]spiroperidol and [3H]ADTN.
    Buczko W; De Blasi A
    Pol J Pharmacol Pharm; 1983; 35(1):45-7. PubMed ID: 6889186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the biological properties of some fibrinogen degradation products (FDP)].
    Malofiejew M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1968; 23():1-65. PubMed ID: 4310706
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of some prostaglandins in the interaction of fibrinogen degradation products (FDP) with central dopamine receptors of rats.
    Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(5):473-80. PubMed ID: 575732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the effect of fibrinopeptides A and B on the central nervous system.
    Bernacka I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):407-14. PubMed ID: 7329866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of fibrinogen degradation products (FDP) on the central action of acetylcholine.
    Zadrozna B; Buczko W
    Pol J Pharmacol Pharm; 1976; 28(6):679-84. PubMed ID: 1012988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinin-like activities of the synthetic low molecular weight fragment of fibrinogen degradation products.
    Takaki A; Yamaguchi T; Ohsato K
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):350-5. PubMed ID: 4281115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fibrinogen degradation products on the rat blood vessels.
    Buczko W
    Acta Physiol Pol; 1977; 28(2):153-9. PubMed ID: 868533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin action of fibrinogen degradation products (FDP).
    Kopeć M; Wegrzynowicz Z; Kloczewiak M; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):417-25. PubMed ID: 4121335
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of trypsin digested globulin degradation products (TDPG) on the activity of central nervous system.
    Wisniewski K; Tarasiewicz S; Maćkowiak J; Buczko W; Moniuszko-Jakoniuk J
    Pharmacology; 1974; 12(6):321-30. PubMed ID: 4456425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):768-82. PubMed ID: 219123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophoretic demonstration of high molecular weight fibrin degradation products persisting in chronic subdural hematomas.
    Toyosawa M; Kashiwagi S; Pei W; Fujisawa H; Ito H; Nakamura K
    Electrophoresis; 1997 Jan; 18(1):118-21. PubMed ID: 9059832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic identification of the cleavage products from the A alpha- and B beta-chains in the early stages of plasmin digestion of fibrinogen.
    Liu CY; Sobel JH; Weitz JI; Kaplan KL; Nossel HL
    Thromb Haemost; 1986 Aug; 56(1):100-6. PubMed ID: 2946092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
    Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.